Faculty profile

George Rodrigues

Back to faculty

Cross-Appointed ProfessorDepartment of Epidemiology and BiostatisticsWestern University

George Rodrigues

Cross-Appointed Professor

Department of Epidemiology and Biostatistics

Schulich School of Medicine & Dentistry

Western University

London, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
14 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

138

Publications

456

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Diffusion Gas Exchange Lung Cancer Lung Injury Magnetic Resonance Imaging Perfusion Radiation Therapy Ventilation

Latest papers

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026).
The Journal of urology · 2026
Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials.
Practical radiation oncology · 2024
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024

All 138 publications

Latest funding

Identification of acute radiation-induced cardiac toxicity after locally advanced non-small cell lung cancer radiotherapy with hybrid PET-MRI
CIHR · 2016 · Co-investigator
$88,750
Hyperpolarized Xenon-129 Magnetic Resonance Imaging of Radiation-Induced Lung Injury
CIHR · 2012 · Principal investigator
$500,264
Economic evaluation of tests to reveal the source of cancers of unknown primary
CIHR · 2010 · Co-investigator
$173,829

All 3 grants and awards

138 publications.

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026).

Eastham JA, Barocas DA, Chu CE, Morgans AK, Rodrigues G, Kirkby E, Pak LJ, Patel S

The Journal of urology2026

DOI: 10.1097/ju.0000000000005060 PMID: 41988960

Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials.

Tang T, Rodrigues G, Warner A, Bauman G

Practical radiation oncology2024

DOI: 10.1016/j.prro.2023.08.006 PMID: 37791942

Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society.

Park HS, Rimner A, Amini A, Chang JY, Chun SG, Donington J, Edelman MJ, Gubens MA, Higgins KA, Iyengar P, Juloori A, Movsas B, Nemeth Z, Ning MS, Rodrigues G, Wolf A, Simone CB

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2024

DOI: 10.1016/j.jtho.2024.09.1386 PMID: 39271016

American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer.

Rodrigues G, Higgins KA, Rimner A, Amini A, Chang JY, Chun SG, Donington J, Edelman MJ, Gubens MA, Iyengar P, Movsas B, Ning MS, Park HS, Wolf A, Simone CB

JAMA oncology2024First author

DOI: 10.1001/jamaoncol.2024.0294 PMID: 38602670

Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer.

Preti BTB, Sanatani MS, Breadner D, Lakkunarajah S, Scott C, Esmonde-White C, McArthur E, Rodrigues G, Chaudhary M, Mutsaers A, Sachdeva R, Vincent MD

Current oncology (Toronto, Ont.)2023

DOI: 10.3390/curroncol30080559 PMID: 37623040

American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma.

Chun SG, Rimner A, Amini A, Chang JY, Donington J, Edelman MJ, Geng Y, Gubens MA, Higgins KA, Iyengar P, Movsas B, Ning MS, Park HS, Rodrigues G, Wolf A, Simone CB

JAMA oncology2023

DOI: 10.1001/jamaoncol.2023.1175 PMID: 37186595

Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice.

Raphael J, Richard L, Lam M, Blanchette P, Leighl NB, Rodrigues G, Trudeau M, Krzyzanowska MK

Journal of the National Cancer Institute2023

DOI: 10.1093/jnci/djad090 PMID: 37195459

ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.

Simone CB, Bradley J, Chen AB, Daly ME, Louie AV, Robinson CG, Videtic GMM, Rodrigues G

Practical radiation oncology2023Senior author

DOI: 10.1016/j.prro.2023.01.005 PMID: 37080641

Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.

Raphael J, Richard L, Lam M, Blanchette PS, Leighl NB, Rodrigues G, Trudeau ME, Krzyzanowska MK

The oncologist2022

DOI: 10.1093/oncolo/oyac085 PMID: 35552444

Performance sensitivity analysis of brain metastasis stereotactic radiosurgery outcome prediction using MRI radiomics.

DeVries DA, Lagerwaard F, Zindler J, Yeung TPC, Rodrigues G, Hajdok G, Ward AD

Scientific reports2022

DOI: 10.1038/s41598-022-25389-7 PMID: 36471160

Profile data last refreshed on November 9, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

George Rodrigues

Research

Latest papers

Latest funding

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026).

Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials.

Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society.

American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer.

Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer.

American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma.

Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice.

ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.

Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.

Performance sensitivity analysis of brain metastasis stereotactic radiosurgery outcome prediction using MRI radiomics.

Identification of acute radiation-induced cardiac toxicity after locally advanced non-small cell lung cancer radiotherapy with hybrid PET-MRI

Hyperpolarized Xenon-129 Magnetic Resonance Imaging of Radiation-Induced Lung Injury

Economic evaluation of tests to reveal the source of cancers of unknown primary

Frequent collaborators

Eric Winquist

Glenn Bauman

Stewart Gaede

Edward Yu

Jeff Chen

Andrew Loblaw

Himu Lukka

Aaron Fenster

Jerry Battista

Grace Parraga

Muriel Brackstone

Craig Lewis

Eric Vigneault

Sisira Sarma

Gregory Pond

Rashid Dar

Piotr Wilk

David Roberge

Ting-Yim Lee

Maureen Trudeau

Michael Brundage

Robert Olson

Ranjan Sur

Malti Patel

Anand Swaminath